# A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise

> **NCT02407704** · PHASE4 · COMPLETED · sponsor: **Kirk Erickson, PhD** · enrollment: 31 (actual)

## Conditions studied

- Depression
- Depressive Disorder, Major
- Depressive Disorder
- Unipolar Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Venlafaxine XR
- **OTHER:** Aerobic Exercise
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT02407704
- **Lead sponsor:** Kirk Erickson, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407704, "A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02407704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*